OBJECTIVE: To determine the most effective, evidence-based approach to the use of platelet transfusions in patients with cancer. OUTCOMES: Outcomes of interest included prevention of morbidity and ...

There is an increasing demand for single donor platelet transfusions due to intensive chemotherapy and blood stem cell or bone marrow transplantation. Platelet transfusions however are expensive and ...

Platelet transfusion thresholds in according bleeding risk and the presence of bleeding. WHO = World Health Organization. “In practice, we see all too often [that] prophylactic transfusion of ...

A group of 12 thrombocytopenic patients, ranging in age from two to fourteen years, were studied. The thrombocytopenia was due to diverse conditions (Table 1). The platelet count ranged from 3000 to ...

THE variability in the natural history of both acquired and idiopathic aplastic anemia makes it difficult to evaluate the success of any specific program of therapy. With careful attention to ...

65.4% of hospitalized ITP inpatients did not have a bleeding episode or surgical procedure associated with their platelet transfusion. Platelet transfusions were not associated with improved clinical ...

Sparrow Health System in Lansing, Michigan, has won a 2018 HIMSS Davies Enterprise Award for its work using evidence-based best practices to reduce non-emergent blood transfusions. Sparrow recognized ...

Promacta tended to boost platelet counts in patients with low-risk MDS, and helped those patients be independent of transfusions, too. Promacta (eltrombopag) improved platelet counts in patients with ...

People hospitalized with certain rare blood cell disorders frequently receive a treatment that is associated with a two- to fivefold increase in death, according to a new study that reviewed hospital ...

Turbulence is a critical physical factor that promotes the large-scale production of functional platelets from human induced pluripotent stem cells, researchers reportl. Exposure to turbulent energy ...

To provide evidence-based guidance on the use of platelet transfusion in people with cancer. This guideline updates and replaces the previous ASCO platelet transfusion guideline published initially in ...